|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Braintree Laboratories |
|---|---|
| Information provided by: | Braintree Laboratories |
| ClinicalTrials.gov Identifier: | NCT00164177 |
Purpose
To evaluate the efficacy of standard HalfLYTELY® as a bowel cleansing preparation for adult patients undergoing virtual colonoscopy (VC).
| Condition | Intervention | Phase |
|---|---|---|
|
Colonoscopy |
Drug: HalfLytely |
Phase IV |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label |
| Official Title: | A Preliminary Evaluation Of The Efficacy Of HalfLYTELY® For Bowel Cleansing Before Virtual Colonoscopy (VC) and Conventional Colonoscopy (CC). |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| ClinicalTrials.gov Identifier: | NCT00164177 History of Changes |
| Other Study ID Numbers: | F38-VC-002 |
| Study First Received: | September 9, 2005 |
| Last Updated: | September 9, 2005 |
| Health Authority: | United States: Food and Drug Administration |
|
virtual colonoscopy colonoscopy preparation bowel prep |